Escalating costs of health insurance premiums since 2000 raise questions about the key driver, rising healthcare costs, as life expectancy hasn’t improved commensurately.

AI-designed T-cell receptors improved cancer-cell killing in the lab and tumor control in mice, pointing toward more effective engineered T-cell therapies.

It’s expected that 2027 will see the largest spike in recent memory of the numbers of un- and underinsured individuals in the United States.

Orexin reveals how a small brain peptide controls wakefulness, explains narcolepsy, and inspires new treatments—and a search for the genome’s hidden proteins.

Trump has publicly slammed pharma and health insurers for their alleged profiteering off the backs of patients. But his administration’s policies have had little impact.

Study finds that psychotherapy during pregnancy can improve depression outcomes and could benefit infant brain and emotional development.

Gene therapy cut severe infections 93% in Wiskott-Aldrich syndrome, using patients’ own modified stem cells to treat a rare inherited immune disorder.

With the rise in premiums and deductibles not included in the CPI increase, it’s evident that certain healthcare costs are enhancing the affordability crisis.

Whole-genome testing uncovered hidden cancer predisposition in children with leukemia, changing treatment and surveillance in a nationwide Swedish study.

Long-read DNA testing diagnosed 35% of previously unsolved inherited muscle disease cases, detecting complex genetic changes missed by standard tests.